Examples of Irish Medicines Board in a sentence
In the event that a product recall or defect notice is issued by the manufacturer, (original supplier) or a medical device regulatory body (such as the Irish Medicines Board) in any country in the world, in relation to the Supplies, or similar goods or services from the same manufacturer, the Supplier shall notify the Purchaser of said recall or defect within five days of the earliest recall or defect.
Irish Medicines Board (IMB)The Competent Authority for implementation of all aspects of the EU Blood Directive is the IMB and regular case review meetings were held with the NHO to discuss reported incidents.
The registry is licensed by the Irish Medicines Board under the EU Tissue Directive 2004/23/EC.Annual Report 2010 41 The IUBMR has been affiliated to the World Marrow Donor Association (WMDA), an organisation which sets operational standards for bone marrow registries worldwide since 1991.
Statutory requirements are laid down in the Irish Medicines Board Acts, 1995 and 2006, and in the regulations relating to the authorisation of medicines, manufacturers, wholesalers and controlled drugs, and the regulations relating to medical devices.
Following a public consultation undertaken by the Department of Health and Children the following was signed into law on 1 May 2007.▪ Irish Medicines Board (Miscellaneous Provision) Act 2006 (No. 3 of 2006) (Section 10(1(ii)).▪ Irish Medicines Board (Miscellaneous Provisions) Act 2006(Commencement) Order 2007▪ Medicinal Products (Prescription and Control of Supply) (Amendment) Regulations 2007, Statutory Instrument No. 201 of 2007▪ Misuse of Drugs (Amendment) Regulations 2007, Statutory Instrument.
The resource most commonly accessed was medicines.ie, the Irish Medicines Board (IMB)’s medicines information website.
This is both a requirement under the Irish Medicines Board Act and a stated objective of the Authority1 of the HPRA.
The Irish Medicines Board (IMB) representative joined NPHET in October, 2009.
The Irish Medicines Board Acts, 1995 and 2006 provide that the advisory committees may establish subcommittees.
New medicines, including new presentations and applications, granted a marketing authorisation by the Irish Medicines Board or European Commission will become reimbursable in the Schemes, within 60 days of the date of the reimbursement application, subject to the provisions of Clauses 4.3 and 5.2. Products which are subject to pharmacoeconomic assessment under Clause 4.3 will become reimbursable in the Schemes within 40 days of a positive reimbursement decision.